Genesis Healthcare, Inc (GEN) is a leading medical care facilities business based in the US. It opened the day at $0.00 after a previous close of $0.22. During the day the price has varied from a low of $0.00 to a high of $0.00. The latest price was $0.00 (25 minute delay). Genesis Healthcare is listed on the NYSE and employs 44,000 staff. All prices are listed in US Dollars.
How to buy shares in Genesis Healthcare
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – GEN – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
Genesis Healthcare stock price (NYSE: GEN)Use our graph to track the performance of GEN stocks over time.
Genesis Healthcare shares at a glance
|52-week range||$0.18 - $1.18|
|50-day moving average||$0.57|
|200-day moving average||$0.58|
|Wall St. target price||$0.53|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.25|
Buy Genesis Healthcare shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Genesis Healthcare stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Genesis Healthcare price performance over time
|1 week (2021-07-21)||N/A|
|1 month (2021-06-27)||N/A|
|3 months (2021-04-30)||-100.00%|
|6 months (2021-01-28)||N/A|
|1 year (2020-07-28)||N/A|
|2 years (2019-07-28)||N/A|
|3 years (2018-07-28)||N/A|
|5 years (2016-07-28)||N/A|
Is Genesis Healthcare under- or over-valued?
Valuing Genesis Healthcare stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Genesis Healthcare's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Genesis Healthcare's EBITDA
Genesis Healthcare's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $160.9 million.
The EBITDA is a measure of a Genesis Healthcare's overall financial performance and is widely used to measure a its profitability.
Genesis Healthcare financials
|Revenue TTM||$3.9 billion|
|Gross profit TTM||$1.7 billion|
|Return on assets TTM||-3.87%|
|Return on equity TTM||0%|
|Market capitalisation||$70.4 million|
TTM: trailing 12 months
Shorting Genesis Healthcare shares
There are currently 2.3 million Genesis Healthcare shares held short by investors – that's known as Genesis Healthcare's "short interest". This figure is 96% up from 1.2 million last month.
There are a few different ways that this level of interest in shorting Genesis Healthcare shares can be evaluated.
Genesis Healthcare's "short interest ratio" (SIR)
Genesis Healthcare's "short interest ratio" (SIR) is the quantity of Genesis Healthcare shares currently shorted divided by the average quantity of Genesis Healthcare shares traded daily (recently around 11.0 million). Genesis Healthcare's SIR currently stands at 0.21. In other words for every 100,000 Genesis Healthcare shares traded daily on the market, roughly 210 shares are currently held short.
However Genesis Healthcare's short interest can also be evaluated against the total number of Genesis Healthcare shares, or, against the total number of tradable Genesis Healthcare shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Genesis Healthcare's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Genesis Healthcare shares in existence, roughly 10 shares are currently held short) or 0.0285% of the tradable shares (for every 100,000 tradable Genesis Healthcare shares, roughly 29 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Genesis Healthcare.
Find out more about how you can short Genesis Healthcare stock.
Genesis Healthcare share dividends
We're not expecting Genesis Healthcare to pay a dividend over the next 12 months.
Have Genesis Healthcare's shares ever split?
Genesis Healthcare's shares were split on a 10:11 basis on 3 April 2013. So if you had owned 11 shares the day before before the split, the next day you'd have owned 10 shares. This wouldn't directly have changed the overall worth of your Genesis Healthcare shares – just the quantity. However, indirectly, the new 10% higher share price could have impacted the market appetite for Genesis Healthcare shares which in turn could have impacted Genesis Healthcare's share price.
Genesis Healthcare share price volatility
Over the last 12 months, Genesis Healthcare's shares have ranged in value from as little as $0.1801 up to $1.18. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Genesis Healthcare's is 1.364. This would suggest that Genesis Healthcare's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Genesis Healthcare overview
Genesis Healthcare, Inc. , together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services; Rehabilitation Therapy Services; and Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy. In addition, the company offers other specialty medical services, such as physician, staffing, and other healthcare related services. As of December 31, 2020, it provided inpatient services through a network of approximately 341 skilled nursing facilities and assisted/senior living communities in 24 states; and supplied rehabilitation and respiratory therapy to approximately 1,400 healthcare locations in 42 states, the District of Columbia and China. The company was formerly known as FC-GEN Operations Investment, LLC and changed its name to Genesis HealthCare, Inc.
Genesis Healthcare in the news
Frequently asked questionsWhat percentage of Genesis Healthcare is owned by insiders or institutions?
Currently 42.338% of Genesis Healthcare shares are held by insiders and 22.791% by institutions. How many people work for Genesis Healthcare?
Latest data suggests 44,000 work at Genesis Healthcare. When does the fiscal year end for Genesis Healthcare?
Genesis Healthcare's fiscal year ends in December. Where is Genesis Healthcare based?
Genesis Healthcare's address is: 101 East State Street, Kennett Square, PA, United States, 19348 What is Genesis Healthcare's ISIN number?
Genesis Healthcare's international securities identification number is: US37185X1063 What is Genesis Healthcare's CUSIP number?
Genesis Healthcare's Committee on Uniform Securities Identification Procedures number is: 37185X106
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert